Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy - Lin - 2021 - Journal of Diabetes Investigation - Wiley Online Library
Bilateral improvement of persistent diffuse diabetic macular oedema after unilateral intravitreal bevacizumab (Avastin) injection | Eye
NW2007 Intravitreal Avastin Injection for Diabetic Retinopathy
Intravitreal Bevacizumab in Diabetic Retinopathy - KSOS
CENTRAL MACULAR THICKNESS REDUCTION AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB COMPARED TO INTRAVITREAL KETOROLAC IN NAIVE DIABETIC MACULAR EDEMA | International Journal of Retina
Full article: Intravitreal bevacizumab treatment for retinal neovascularization and vitreous hemorrhage in proliferative diabetic retinopathy
Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity | NEJM
Avastin - anti-Vascular Endothelial Growh Factor for Ocular Disease
Rapid regression of disc neovascularization in a patient with proliferative diabetic retinopathy following adjunctive intravitreal bevacizumab | Eye
Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinic
A-C) Color photographs before intravitreal bevacizumab. Severe... | Download Scientific Diagram
Another Proliferative Diabetic Retinopathy? A Case Report of Retinal Cavernous Haemangioma Treated with Intravitreal Bevacizumab, Initially Labelled as Persistent Proliferative Diabetic Retinopathy
PDF) Effect of laser photocoagulation and bevacizumab intravitreal in proliferative diabetic retinopathy: review on biomarkers of oxidative stress | Habibah Muhiddin and Adang Bachtiar - Academia.edu
Fellow eye effect of unilateral intravitreal bevacizumab injection in eyes with diabetic macular edema | Eye
Intravitreal Bevacizumab for Treatment of Diabetic Macular Edema
Another Proliferative Diabetic Retinopathy? A Case Report of Retinal Cavernous Haemangioma Treated with Intravitreal Bevacizumab, Initially Labelled as Persistent Proliferative Diabetic Retinopathy
Preferable use of intravitreal bevacizumab as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy | Eye